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Abstract
Organized assembly or aggregation of sphingolipid-binding ligands, such as certain toxins and pathogens, has been
suggested to increase binding affinity of the ligand to the cell membrane and cause membrane reorganization or distortion.
Here we show that the diffusion behavior of the fluorescently tagged sphingolipid-interacting peptide probe SBD
(Sphingolipid Binding Domain) is altered by modifications in the construction of the peptide sequence that both result in a
reduction in binding to ganglioside-containing supported lipid membranes, and at the same time increase aggregation on
the cell plasma membrane, but that do not change relative amounts of secondary structural features. We tested the effects
of modifying the overall charge and construction of the SBD probe on its binding and diffusion behavior, by Surface
Plasmon Resonance (SPR; Biacore) analysis on lipid surfaces, and by Fluorescence Correlation Spectroscopy (FCS) on live
cells, respectively. SBD binds preferentially to membranes containing the highly sialylated gangliosides GT1b and GD1a.
However, simple charge interactions of the peptide with the negative ganglioside do not appear to be a critical determinant
of binding. Rather, an aggregation-suppressing amino acid composition and linker between the fluorophore and the
peptide are required for optimum binding of the SBD to ganglioside-containing supported lipid bilayer surfaces, as well as
for interaction with the membrane. Interestingly, the strength of interactions with ganglioside-containing artificial
membranes is mirrored in the diffusion behavior by FCS on cell membranes, with stronger binders displaying similar
characteristic diffusion profiles. Our findings indicate that for aggregation-prone peptides, aggregation occurs upon contact
with the cell membrane, and rather than giving a stronger interaction with the membrane, aggregation is accompanied by
weaker binding and complex diffusion profiles indicative of heterogeneous diffusion behavior in the probe population.
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Introduction
Numerous pathogenic proteins and viruses utilize sphingolipid-
containing domains in the plasma membrane of the target cell as a
means of docking and entry into the cell [1]. The dynamics with
which sphingolipid-interacting domains found in such proteins
engage with their lipid receptors and move in the plane of the
membrane has been proposed to involve a weak interaction of
aromatic amino acids with carbohydrate-modified glycolipids or
acidic gangliosides [2], providing the initial step to a stronger
protein receptor-pathogen interaction [3,4,5,6,7].
Clustering of glycolipids at the membrane by multimerization of
ligands is a common mode of interaction by pathogen attachment
proteins that increases binding strength and facilitates internali-
zation [2,8,9,10] by bending or tubulating membranes and
coalescing microdomains, e.g. in the case of SV40 and the AB5
toxins [11,12,13,14] such as Cholera toxin B (CtxB) [15,16,17,18].
The Alzheimer’s disease-causing Ab peptide, like these toxins, may
cluster at the membrane, seeded by gangliosides, into oligomers or
aggregates of anywhere from a few molecules to larger protofibrils,
or large pore-forming annuli [19,20,21,22,23,24,25,26,27]. Lipid
interactions, especially with gangliosides, have also been reported
to induce conversion of the Ab peptide, from random coil to a-
helix, or helix to b-sheet [20,25,28], which is thought to enhance
oligomerization and/or aggregation and affect uptake [29,30].
The effect of such aggregation and clustering on the diffusion
dynamics and stability of sphingolipid-binding ligands at the
membrane has not been studied systematically. However, some
evidence exists that higher-order oligomeric Ab molecules or
aggregates, rather than binding more tightly, lose the capacity to
bind the membrane, and that primarily monomers or small
clusters of the peptide associate with the membrane [29,31,32] and
induce regions of immobility and/or decreased fluidity, depending
on membrane composition [29,33,34]. It is not established
whether unstructured aggregation would lead to membrane
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coalescence or stimulate uptake as does CtxB, which has a much
greater affinity for the membrane than Ab [25,35,36,37]. In
neither case is it known how aggregation affects mobility at the
membrane.
The Sphingolipid Binding Domain peptide (SBD) is a fluores-
cently tagged peptide probe derived from the first 25 amino acids
of the Ab sequence, which we previously characterized as a tracer
of sphingolipid trafficking pathways in the cell [38,39] and of
membrane dynamics of sphingolipid-containing domains [40,41].
Identified by Fantini and his group as a potential glycosphingolipid
(GSL)- and sphingomyelin (SM)-interacting sequence in Ab, the
isolated SBD peptide was previously shown by liposome capture
experiments and surface plasmon resonance (SPR) assays [38] to
interact with gangliosides. Somewhat surprisingly, this short
sequence tagged with tetramethylrhodamine (TMR) showed a
preference similar to what was reported for the full length Ab1–40
peptide [25,27], preferring more highly sialylated species GT1b
and GD1a to GM1 at neutral pH, suggesting that a critical
sphingolipid-targeting motif may indeed reside in these first 25
amino acids. SBD’s interaction with the plasma membrane of cells
was dependent on the presence of cholesterol, SM, and glycolipid
[38,39,40,41] similarly to full-length Ab 1–40 and 1–42, which
interact with phospholipids, cholesterol, and gangliosides
[20,23,28,37,42,43,44,45,46,47]. A characteristic cholesterol-de-
pendent bimodal diffusion behavior of SBD at the membrane was
furthermore demonstrated, like other ganglioside interacting
probes such as CtxB [40,41].
In the present study, using surface Plasmon resonance (SPR)
and molecular dynamics (MD) simulations, we showed that
variations in the linker construction and charge of the SBD
peptide influenced binding strength to simplified, ostensibly
plasma membrane-like ganglioside-containing membranes without
inducing major structural changes. This gave us an interesting
opportunity to test the effects of binding strength to gangliosides
on diffusion behavior of the probes. As an indicator of the diffusion
behavior of the peptides in the presence of the plasma membrane,
we measured the different SBD variants by confocal fluorescence
correlation spectroscopy (FCS) on live cell membranes. A
comparison of the SPR binding and FCS assays revealed that an
increase in aggregation propensity of certain SBD variants
occurred at the plasma membrane, accompanied by very slow
diffusion, and rather than improving binding, these aggregating
variants showed poorer binding to ganglioside-containing mix-
tures.
Materials and Methods
Peptide preparation and cell labelling
The SBD E16 variant with amino-ethoxy-ethoxy-acetyl
(AEEAc)2 linker (fig. 1) was synthesised by Bachem (Switzerland),
or by an in-house peptide synthesis core facility by standard Fmoc
chemistry. For the polyethylene glycol (PEG)-linked variants of
SBD, four PEGs were coupled to the N-terminal of the peptide as
a spacer between the TMR dye and the peptide (fig. 1). PEG- and
AEEAc-linked peptides had molecular masses of 3635 kDa and
3636 kDa, respectively. Handling and labelling of cells with SBD
was done as described in [38,41]. Cells labeled with peptides were
imaged on a DeltaVision widefield fluorescence deconvolution
microscope (Applied Precision, Inc., WA, USA) with a PLAPON
606/1.42 NA oil-immersion objective from Olympus, and
TRITC Semrock filters (New York, USA).
SPR assays
Palmitoyl-oleoyl-phosphatidylcholine (POPC)/sphingomyelin
(SM)/Cholesterol (Chol) (45:25:30 molar ratio), POPC/SM/
Chol/GT1b (45:25:30 with 10% GT1b), POPC/SM/Chol/
GD1a (45:25:30 with 15% GD1a), POPC/Chol (70:30), or
POPC/Chol/GT1b (70:30 with 10% GT1b) liposomes were
prepared in HBS-N buffer (10 mM HEPES, 150 mM NaCl)
pH 7.4 using a standard extrusion method. Briefly, liposomes were
prepared by mixing the different components together in a glass
vial at room temperature, and dried under a nitrogen stream. To
remove the organic solvent in which the components were
dissolved, the lipid was lyophilized for at least two hours. The
final lipid concentration of 0.5 mM was reached by re-dissolving
the lipid film in 1 mL HBS-N and vortexing thoroughly for
10 min. The formation of a lamellar structure was supported by
freezing the mixture in liquid nitrogen, followed by thawing in a
hot water bath, repeated five times. The lipid film was completely
removed from the inside wall of the glass vial by bath sonication in
ice water for at least 30 minutes. The solution was extruded
through a 50 nm membrane 51 times to yield small lipid vesicles.
The liposomes produced were stored at 4uC for no longer than
one week between experiments to prevent the formation of
liposome clusters. The size of the liposomes was assessed by
Dynamic Light Scattering on a Malvern Zetasizer (Worcestershire,
UK).
Lipids were from Avanti (Alabaster, AL) or Carbosynth
(Compton, UK). Solvents and other reagents were from Fisher
Scientific (Waltham, MA), Merck (Whitehouse Station, NJ), GE
Healthcare (Uppsala, Sweden), and Calbiochem (San Diego, CA).
SPR assays were carried out on a Biacore 3000 instrument with L1
chips (GE Healthcare), according to [41]. The tubing was cleaned
prior to each experiment according to the method given by the
manufacturer with 40 mM OG and de-ionized water and left on
standby overnight in Milli-Q water. Liposome solutions were
injected until the immobilization level reached at least 5000 RU,
except for POPC/SM/cholesterol/GD1a and POPC/cholester-
ol/GT1b mixtures, for which only lower immobilizations could be
reached.
Peptide solutions were prepared freshly in HBS-N buffer,
pH 7.4 (see above) to give a final concentration of 35 mM. 40 ml of
peptide was injected over the lipid surface at a flow rate of 10 ml/
min and the peptide-surface complex was allowed to dissociate in
buffer for 15 min. The carrier buffer HBS-N was injected prior to
the peptide injection and each peptide injection was performed on
a freshly prepared surface.
The values given in the graph in fig. 2 were an average from at
least 3 flow cells. The ‘‘fraction binding’’ value in fig. 2A was taken
from the association phase data, excluding the first 30 seconds
after the start of peptide injection. Fraction binding was calculated
by taking the difference between the height of the curve in
response units (RU) at the start of the peptide injection phase from
the height of the curve at the end of the peptide injection phase
(see fig. S1), divided by the normalized immobilization level. The
normalized immobilization level for a flow cell was the amount of
liposome bound to the chip at that flow cell, after the value at each
flow cell had been normalized to the average over all flow cells.
The value for ‘‘fraction bound’’ in fig. 2B was determined by
taking the height of the curve (in RU) after 15 mins of dissociation,
divided by the normalized immobilization level.
FCS experiments
FCS experiments were done on an Olympus FluoView 300
confocal microscope with the custom-built FCS detection unit on
top of the scanning unit. A 543 nm helium-neon laser was used to
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excite the TMR fluorophores and the laser power was maintained
at 25 mW for all experiments. Details of the instrumentation are
described in [41]. The fluorescence signals were collected onto a
single photon sensitive avalanche photo diode (APD; SPCM-
AQR-14, Pacer Components, UK) after passing through an
emission filter 595 AF60 (Omega Optical Inc., Brattleboro, VT) in
point-scanning mode, and fitting of autocorrelation curves was
done as described [41] using a self-written program in IgorPro 6.0
(Wavemetrics, Portland, OR) with 2D or 3D and 1- or 2-particle,
1 triplet models, yielding diffusion times tD1 and tD2 and



























Figure 1. Structures of the five main SBD peptide variants used in this study. The linker structure between the peptide and the N-terminal
TMR fluorescent tag is shown, as well as the C-terminal ending.
doi:10.1371/journal.pone.0051222.g001
Figure 2. Surface Plasmon Resonance (Biacore) assay of SBD variants’ association with immobilized liposomes. Surfaces with and
without sphingolipid and ganglioside consisted of the mixtures listed below the X-axis. (A) Fraction binding on the Y-axis refers to the peak height of
the association curve in response units (RU), normalized to the average immobilization level over all flow cells for that experiment, indicated by the
numbers (in RU) under the graph. The value for fraction binding was obtained by averaging this normalized peak value for at least three flow cells
(see Materials and Methods). (B) Fraction bound on the Y-axis refers to the height of the dissociation curve in RU, normalized to the average over all
flow cells for that experiment. The error bars represent the variation in the magnitude of response between flow cells.
doi:10.1371/journal.pone.0051222.g002
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Here N refers to the number of particles in the observation
volume; tD1 and tD2 are the characteristic diffusion times of
different particles; the mole fraction of particle 2 is given by F2= 1-
F1; the fraction of molecules in the triplet state and the
characteristic triplet state time are given by Ftrip and ttrip,
respectively. It should be noted that the mole fractions F1 and
F2 are strongly dependent on the actual molecular brightness of
the molecules with brighter molecules contributing more strongly
to the autocorrelation function and biasing the fractions towards
the brighter species. In our experiments, where we have possible
aggregates of fluorescent peptides, one would expect an overes-
timated fraction of the aggregates.
In a homogeneous solution of fluorescently labelled probes, the
autocorrelation function will be reproducible over many measure-
ments with little deviation. However, in heterogeneous solutions in
which there are rare components with a higher brightness and a
lower diffusion coefficient, one will detect characteristic intensity
peaks or spikes of the brighter and rarer species and a change of
the characteristic shape of the correlation function to a model of
higher complexity (two or more particles instead of a single
diffusive component) in a subset of the measurements.
Quantification of the occurrence of spikes in the fluorescence
intensity traces and deviation from normal fitting in the
autocorrelation curves, respectively, was done manually according
to the following criteria: a spike was defined as a sudden jump in
the intensity trace of more than five times the fluctuation range
(highest to lowest) around the average intensity for that sample.
Autocorrelation curves that could not be fitted in the longer time
ranges (i.e. .1 sec lag times) to the normal 2-particle fitting model
were assessed by visual inspection; abnormally long diffusion
times, indicative of immobility, together with spikes in intensity,
which correlated strongly with distortions in autocorrelation
curves at long time ranges, were taken as indicators of probe
aggregation.
REMD simulations
200 nanosecond (ns) replica-exchange molecular dynamic
(REMD) simulations [48] for every SBD monomer were
performed using the Gromacs 4.5 program [49,50,51]. 32 replicas
were applied for each REMD simulation at 297 to 554uK. The
final overall exchange rate was larger than 50%. Amber 99SB
force-field parameters [52] were applied in this REMD study.
Each monomer model was solvated in implicit solvent with no
pressure [53]. The time-step was set to 2 fs throughout the
simulations. V-rescale coupling [54,55] was used for the temper-
ature control. No pressure coupling was used in this study. The
pair-list of the non-bonded interaction was recalculated every 10
time-steps with a pair-list cut-off distance of 10 A˚. The LINCS
routine [56] with a tolerance of 10E-4 was used in all simulations.
The atomic coordinates and velocities were saved every 5 ps. The
secondary structure of the protein was assigned by the DSSP
program [57]. The secondary structure probability and backbone
dihedral angle distribution were analyzed in Ramachandran plots
for each residue (fig. S2).
Circular Dichroism (CD) Measurements
Circular dichroism measurements were performed on a
Chirascan spectropolarimeter (Applied Photosystems) using a
rectangular 1 mm quartz cell at 23uC. Data were acquired with
a pitch of 1 nm between 270–190 nm with an averaging time of
1 sec. 10 scans were averaged and smoothened for each sample.
Peptide concentrations in 50 mM potassium phosphate buffer,
pH 7.4, were determined by measuring the absorbance of the dye
(TMR) coupled to the peptide, using a Cary 300 Bio UV-Vis
Spectrometer (Varian) at 556 nm. The extinction coefficient for
TMR was 90000. Ultimately, all spectra were baseline corrected





where [h]l is the MRE at wavelength l in deg cm2 dmol21, l is
the path length in cm, c is the concentration in M, n is the number
of residues and (n-1) designates the number of peptide bonds in the
studied polymer. In 50% trifluoroethanol (TFE) the AEEAc-linked
peptide changed conformation into predominantly helical, indi-
cating that the presence of linker does not obstruct the peptide
from undergoing conformational changes.
Results
1. Charge interactions are not critical to ganglioside
binding of a sphingolipid-interacting peptide probe, the
SBD
A fluorescently tagged ganglioside- and sphingomyelin-interact-
ing 25 residue peptide derived from the amyloid peptide Ab, the
Sphingolipid Binding Domain (SBD) probe (shown in fig. 1) was
described in previous work as a tracer of sphingolipid-containing
domains in cellular membranes. SBD binds in the micromolar
range to a constellation of GSL, SM, and cholesterol, with GT1b
being the optimum ganglioside among several tested by liposome-
capture studies and SPR [38].
Since SBD does not possess the toxic properties of Ab [38] and
lacks the most aggregation-prone, b-sheet forming region of Ab
between amino acids 28 and 42 [20,22,58], it allows us to examine
the consequences of glycosphingolipid (GSL) binding on diffusion
behavior, independent of fibrillization, pore-forming, or penetra-
tion effects. The binding preference of the 27 net charged SBD
peptide AEEAc-E16-COO- is influenced by pH, with lower pH
buffers giving much stronger interactions with less-sialylated
gangliosides, notably GM1 [38,47,59]. It has not been tested
whether a possible repulsive effect of the sialic acid groups with the
negatively charged peptide might be overcome by reducing the net
negative charge. We tested this idea by introducing stepwise
increases in the overall charge of the peptide and monitoring their
effect on binding by SPR measurements on immobilized POPC/
SM/Chol (45:25:30 molar ratio) or POPC/Chol (70:30) liposomes
[60] with 10% or 15% GT1b or GD1a ganglioside, on dextran-L1
chips (GE Healthcare). All SPR binding curves obtained with the 5
peptide variants (whose compositions are shown in fig. 1) on
different lipid mixtures are given in figure S1, and the
quantification of binding at the peak of the association curve,
and after dissociation are shown in figure 2A and B (‘‘fraction
binding’’ vs. ‘‘fraction bound’’; see Methods for explanation of
how the values were obtained).
A naturally occurring variant of Ab with glutamate at position
16 instead of lysine does not lead to major structural changes,
according to an NMR study of Ab1–28 [61]. This gave us the
opportunity to avoid inducing drastic structural changes in the
peptide, while increasing the net charge, by introducing K16 in
place of E16 in the original SBD sequence (fig. 1). The fraction of
peptide bound at the peak of the association curve (fig. 2A), and
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the fraction remaining bound after dissociation (fig. 2B) were,
surprisingly, consistently lower on GSL for the PEG-K16-SBD
peptides than the equivalent E16 SBD (purple vs. maroon; olive vs.
dark blue). For the non-GSL containing surfaces, the K16 peptides
bound even more poorly in comparison to all three E16-containing
peptides (olive/purple vs. dark blue/maroon).
When the C-terminal carboxylic acid was modified by an amide
(NH2), increasing the positive charge by an additional +1 (see fig. 1),
the K16 and E16 peptides showed improved binding to GSL (olive
vs. purple; dark blue vs. maroon, fig. 2), in particular when more
ganglioside was present, in the POPC/SM/Chol/15% GD1a
mixture. However, it is notable that these less negative peptides did
not perform nearly as well as the most negative AEEAc-E16-COO-
peptide (light blue), suggesting that simply increasing the positive
charge of the probe does not improve binding to acidic gangliosides
per se. Rather, it appears that the presence of an amide group,
either as an addition at the C-terminus, or via the AEEAc linker,
improves binding strength to ganglioside containing mixtures,
especially in the context of the E16 peptide.
2. An amide-containing PEG linker stabilizes binding to
ganglioside-containing surfaces
Alternate versions of the peptide were synthesized, with
AEEAc2 replaced by (PEG)4 (fig. 1), to examine the effect of
removing the amine group within the linker. The AEEAc2-
peptide (light blue bars in fig. 2) exhibited higher binding than the
equivalent PEG-peptide (maroon), as well as the more positively
charged PEG peptides (dark blue, olive, purple), as long as GSL
was present (POPC/SM/Chol/10% GT1b or 15% GD1a), but
this was not exclusively due to the AEEAc linker, since a sequence
mutated at two amino acids (R5A, Y10A) that binds much less well
to cell membranes [38] showed reduced binding (pink).
Inclusion of SM in the GSL mixture improved binding of AEEAc-
E16-COO- slightly (light blue, fig. 2), but did not have a positive effect
on the other peptides (dark blue, maroon, purple). In contrast, when
SM was present, but no ganglioside, in the POPC/SM/Chol
mixture, the PEG-E16 peptides performed better than the AEEAc-
E16-COO- (dark blue and maroon vs. light blue). These results
indicate a positive interaction between SBD and SM, that also
depends on the ganglioside surroundings, and that may be influenced
by the presence of an amine in the linker. The linker-borne amine,
however (light blue), does not seem to have the equivalent effect to a
C-terminal amine in an otherwise similar peptide (dark blue).
To differentiate between electrostatic effects and specificity for a
particular ganglioside, we substituted 15% GD1a, which carries two
negative charges, for 10% GT1b, which has three, in an otherwise
identical lipid mixture. All of the SBD peptides showed improved
binding to the higher percentage GD1a-containing mixture (fig. 2).
GD1a is much more highly represented than GT1b in the SH-
SY5Y neuroblastoma cells used in the FCS experiments [62] (see
sections 4–6, below), but was found to be slightly less favored than
GT1b in previous liposome capture experiments with SBD [38]. In
summary, inclusion of an amine-containing linker or terminus, but
not changes in overall charge per se, lead to substantial
improvements in the ability of the peptide to bind to plasma
membrane-like GSL-containing surfaces.
3. Replica exchange simulations show no change in
relative amounts of structural motifs, but an increased
frequency of random coil in the best binding SBD
variants
We modeled the different SBD monomer variants by replica-
exchange molecular dynamics (REMD) simulations, which
enhance the conformational sampling of peptides by combining
high temperature simulations with a Monte Carlo algorithm. The
generally poorer binding of the K16 containing peptides was not
explained by major structural changes, since relative amounts of b-
sheet, turn, bend, and a-helix were similar, and in the absence of
linker only marginally increased b-sheet content. In simulations of
E16-SBD with AEEAc or PEG4 linker, the conformation of the
peptide stabilized from ,90% random coil to being more
structured (fig. 3). Ramachandran plots and numerical frequencies
of the occurrence of each structural feature are shown in fig. S2.
No significant differences in the frequency of the structure classes
were noted between the AEEAc and PEG linker, although b-sheet
was slightly but not significantly increased in the PEG-linked
version at the apparent expense of a-helix (fig. 3; S2). The K16E
change did not significantly alter the frequency of different
structural features.
In concurrence with the REMD simulations, CD measurements
of peptides in 50 mM potassium phosphate buffer, pH 7.4, did not
reveal any detectable differences in structure, and showed the
conformation of all the peptides to be random coil (not shown).
4. SBD variants that compromise ganglioside binding
diffuse slowly
We asked whether variants that compromised binding to GSL
would have consequences for diffusion behavior on actual cell
membranes. Confocal FCS measurements were carried out on
neuroblastoma SH-SY5Y to measure diffusion times, tD, defined
as the average transit time through the confocal volume. For FCS
measurements on the membrane, autocorrelation functions (ACFs)
fitted a 2D, 2P model, indicative of the probe falling into two
diffusion classes deriving from bound and unbound molecules. As
expected [41] a bimodal distribution was seen for all the SBD
variants, with the exception of PEG-K16-NH2 (fig. 4). Notably,
the two best ganglioside-binding SBD variants, AEEAc-E16-
COO- and PEG-E16-NH2, displayed very similar bimodal
distribution profiles and diffusion times of ,50 ms (fig. 4A–C).
The worst-performing peptides with respect to ganglioside
binding–particularly PEG-K16-NH2–were also the slowest-diffus-
ing, having average tD values much longer than the better-binding
E16 versions (fig. 4C).
5. SBD variants that compromise ganglioside binding
aggregate at the cell membrane
In the SPR assays, peptides with the amide AEEAc-linker
bound better to ganglioside-containing surfaces than PEG-only
linker, and the PEG-E16 with amidated C-terminus was in turn
superior to those with K16 or without the amidation. Binding
efficacy was also associated with particular FCS diffusion profiles
on cell membranes. Typical examples of intensity traces and ACFs
of the different SBD variants applied are shown for AEEAc-E16-
COO- and PEG-K16-NH2, the best- and worst-binding variants,
respectively (fig. 5A–D, E–H). There was a high frequency (22–
59%; fig. 6) of aggregation in PEG-linked peptides, indicated by
fluorescence intensity spikes, like those in fig. 5F. The occurrence
of spikes was much lower for the AEEAc2-containing SBD (9%;
fig. 5B; summarized in fig. 6). Intensity spikes were notably absent
from measurements of any of the peptides in solution. As with the
diffusion times, the two SBDs that interacted most strongly with
GT1b by SPR (AEEAc-E16-COO- and PEG-E16-NH2), were
also the two that had the fewest intensity spikes (fig. 6).
Measurement of the fraction of particles with longer diffusion
times, tD1, vs. shorter diffusion times, tD2, gives information about
the total fraction of probe bound, because freely diffusing unbound
Aggregation-Dependent Dynamics of SBD Peptide
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Figure 3. Secondary structure probability distributions for the different SBD variants. Secondary structure propensity (DSSP) analysis
from 200 ns REMD simulations, showing the percentage of the time that each structure occurs. Amino-PEG (AEEAc2)-linked and PEG4-linked forms of
the E16 peptide with a carboxy terminus were compared in order to assess possible effects of the linker on structure. The different linkers appeared
to have no significant effect on the occurrence of structural features. The last four groups show the distribution of structural features that occur in the
four variants, either E16 or K16, and with carboxy (COO-) or amide (NH2) termini, in the absence of linker. The inclusion of E vs. K at position 16 affects
the frequency of random coil, but does not appear to otherwise change the relative amounts of structural features. Ramachandran plots showing the
distribution of peptide bond angles, and exact frequencies of each structural feature are given in fig. S2.
doi:10.1371/journal.pone.0051222.g003
Figure 4. Histogram and average diffusion times derived from FCS measurements on SBD variants in neuroblastoma cells. (A)
Histogram distribution of tD values with the confocal volume centered on the plasma membrane, over the indicated times ranges in milliseconds for
all five SBD variants listed in the key. All variants show a bimodal distribution of tD values except for weakest binding PEG-K16-NH2. The .30 ms
group in (A) is redistributed in (B) over the indicated time ranges. (C) Table of average tD values on the membrane and in solution 6 standard
deviation. Average values were derived from n.60 measurements for each probe either at the membrane or in solution.
doi:10.1371/journal.pone.0051222.g004
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probe gives exclusively short tDs, in the range of hundreds of msec,
while membrane-bound probes typically have tDs of ,1–
100 msec [39]. The poorly binding PEG-K16-NH2 peptide not
only had the greatest frequency of intensity spikes, but also showed
an unusually low fraction (21.7%) of bound tD1 particles, vs. 43.8–
51.6% for the other variants (fig. 6B).
Figure 5. FCS autocorrelation curves and intensity traces on SBD variants labelling neuroblastoma cells. Normalized ACFs (left; traces)
and 2D,2p models (left; line curves), with lag time of the autocorrelation function G(t) indicated in seconds on the X-axis. Corresponding intensity
traces are given on the cell membrane (A, B, E, F) and in the solution (C, D, G, H) for SBD with either the amine-PEG AEEAc linker, E16, and COO-
terminus (A–D), or for SBD with a PEG linker, K16, and an amidated C-terminus (E–H). Deviations in the ACF from the fitting model occur between
,1–10 sec in the measurement of PEG-K16-NH2 on the membrane (E), and spikes in the corresponding intensity fluctuation trace for the membrane
measurement in (F) are evident, but not in the ACFs and intensity traces for AEEAc-E16-COO- (A, B) or for either peptide in solution (C, D, G, H). tD
values indicated correspond to the particular graphs shown in the figure and not the average values.
doi:10.1371/journal.pone.0051222.g005
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In some cases, ACFs deviated from the 2D, 2P model in the 1–
10 s range of the curve (e.g. fig. 5E). These complex correlation
functions were seen predominantly for the poorly GSL-binding
PEG-linked SBDs, and presumably arose from a small fraction of
particles having extremely long diffusion times (see above, and
fig. 4B). Intensity spikes arising from large fluorescent particles
diffusing through the confocal volume were strongly correlated
with complex ACFs like those obtained with PEG-K16-NH2
(figs. 5E; see [63]). Immobile aggregates of the K16 peptides at the
membrane may produce long diffusion times (.100 ms; fig. 4C),
and bleach, distorting the ACFs [64,65,66].
The frequency of complex ACFs with non-fitting in the 1–10 s
range is given in fig. 6, and their correlation with spikes in intensity
traces is shown as a Venn diagram in fig. 7. This diagram shows
schematically the degree of correspondence between complex
ACFs and the occurrence of spikes in intensity traces, with the size
of the overlapping areas proportional to the amount of actual
overlap between groups. In general, spiked intensity traces were
also those that resulted in complex ACFs displaying distortions at
longer lag times, e.g. for PEG-E16-NH2 and PEG-K16-COO-
peptides, these were completely overlapping. However, it was
noted that for the worst-binding PEG-K16-NH2 peptide, the
correlation between spiking and complex ACFs is less good than
for the others (i.e. the overlap between beige and green is less
complete), suggesting that in this case, aggregated slow particles
dominated the ACF, rather than being a rare occurrence that only
distorted it at long lag times (see fig. 7). Non-aggregating
membrane dyes such as 1,19-Dioctadecyl-3,3,39,39-Tetramethy-
lindocarbocyanine Perchlorate (DiI) do not produce complex
ACFs [40,41]. The fact that intensity spikes and complex ACFs
appeared only in readings at the plasma membrane, and were
negligible for all peptides in solution, suggests that aggregation of
any of the SBD variants occurred exclusively upon contact with
the cell membrane.
6. All SBD variants are endocytosed by cells
Cell labeling on neuroblastoma SH-SY5Y as was done for the
FCS experiments, and subsequent wide-field fluorescence imaging
after 1 hour of uptake, showed that all variants of the peptide were
endocytosed by the cells, with no obvious difference in surface
distribution (fig. 8), even though diffusion and aggregation
behavior clearly differed between peptides. Any differences in
surface distribution may be undetectable by conventional fluores-
cence microscopy due to a resolution limit likely exceeding the
dimensions of the range of areas bound by the peptide at the
membrane.
Discussion
In this study, we compared the binding and diffusion behaviour
of several variants of the Ab-derived SBD (Sphingolipid Binding
Domain) probe that consisted of a change in the charge and
terminal modification of the peptide, without an overall change in
structure. The variations changed the ability of the SBD to bind to
its usual targets—gangliosides GT1b and GD1a in plasma
membrane-like mixtures, and this decrease in binding propensity
Figure 6. Frequency of aggregation and non-binding of SBD variants. Spiked intensity traces and complex ACFs by FCS indicated
aggregation of SBDs. A complex ACF is defined as deviating from the fitting model in the time-lag range of 1–10 sec. The last two columns show the
fraction of peptide assumed to be bound to the membrane, based on %tD1 (millisecond range) vs. %tD2 (microsecond range). Spikes were counted in
each measurement over 20 seconds.
doi:10.1371/journal.pone.0051222.g006
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to GSL correlated with an increase in aggregation behaviour at the
plasma membrane, and slowed diffusion by FCS.
Variants of the SBD containing a positive K16 in place of
negative E16, although as expected [61] did not give any structural
changes in MD simulations, led to relatively large changes in
interactions with gangliosides. Surprisingly, the two K16 variants
displayed the weakest interactions with SBD’s target GSL, GT1b
[38]. These results indicate that interaction between the SBD
peptide and ganglioside-containing surfaces is not non-specifically
electrostatic in nature, and may depend upon other interactions,
e.g. CH-p stacking typical for lectin binding to carbohydrate [3].
This was also proposed to have a role in the binding of glycolipid
sugar-rings to aromatic residues in Ab [47,67] as well as the
sphingolipid binding domains of various proteins.
Most SBD variants showed one slow population with tD
,50 ms or longer, which was earlier shown to be cholesterol-
dependent [41], and a second faster-diffusing non-cholesterol-
dependent population, having tD ,1–10 ms. In contrast, the
poorly binding PEG-K16-NH2 variant showed a much longer (i.e.
slower), unimodal tD distribution than the others, with PEG-K16-
COO- being a distant second, indicating a lower mobility of this
variant. PEG-K16-NH2 also had correspondingly the highest
number of intensity spikes and lowest bound fraction to cell
membranes, whereas the tD values of all the variants were similar
Figure 7. Correlation of aggregation-induced intensity spikes with complex autocorrelation curves in the different SBD variants. (A)
Correspondence of spikes in intensity traces with incidence of non-fitting of the ACF with the 2D,2p model (curves in fig. 4) between 1–10 sec
(‘‘complex’’ ACFs). The number of ACFs and intensity traces observed in each case is given in brackets. For the AEEAc-E16-COO- peptide, the number
of spiked intensity traces and complex ACFs was very low compared to the others (n = 9 and 7, respectively). (B) Venn diagrams illustrating the degree
of correspondence between readings showing spikes in intensity traces (green circles), vs. those that do not (blue circles) and readings having
complex ACFs (beige circles), for each SBD variant. The actual relative proportions of readings in each category, as well as the proportion of readings
that were shared between categories, are represented by the relative sizes of the circles and overlaps.
doi:10.1371/journal.pone.0051222.g007
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in the extracellular solution. Measurements in solution produced
intensity traces that lacked spikes and fitted well with 3D,1P
diffusion models, suggesting that any aggregation that did occur
happened only after contact with the plasma membrane. Notably,
inclusion of the AEEAc linker appeared to suppress aggregation, at
the same time that it improved binding capacity to GSL in the
SPR studies.
These observations are consistent with ganglioside-seeding
models of full length Ab’s interaction with the membrane [68],
and suggest that the first 25 aa may be sufficient for this seeding
activity, as described by Williamson et al [69]. Moreover, the fact
that the more common K16 isoform [61] exhibits more
membrane-induced aggregation and less avid membrane binding
in our shorter SBD peptide, suggests a possible preference of the
E16 mutation for binding in monomeric or small oligomeric form,
because of ganglioside interactions. While it is surprising that the
more positively charged K16 and C-terminal NH2 versions bind
less well to negative gangliosides in our hands, this is also
consistent with the findings of Ikeda et al [47] and others who
postulate that hydrogen bonding and CH-p interactions of
aromatic amino acids in Ab with sugar head-groups of ganglio-
sides are more important determinants of the interaction, and may
in fact protect against aggregation [70]; indeed this would be one
plausible explanation for the results we see, where peptides that
bind better to gangliosides actually aggregate less. For the weaker
ganglioside binders, one can imagine that the peptide might not
aggregate in solution where individual peptide molecules are freely
diffusing in three dimensions, but when loosely bound to the
membrane by a weak lipid interaction, they could come into close
enough proximity in only two dimensions, such that aggregation
occurs more readily, and is not hindered by interaction with
gangliosides. An alternative model derived from FRET studies of
fluorescent Ab with lipid vesicles states that GM1 does not bind to
Ab with appreciable affinity, but rather serves as a seed for the
fibrillization that occurs upon contact with the membrane,
switching Ab’s affinity to POPC [71]. This may also be consistent
with our findings.
Membrane-induced aggregation may be similar to the prion
protein (PrP) which is normally found in non-aggregating a-helical
form (PrPC), but upon interaction with membranes can be induced
to form b-sheet and convert to the pathogenic PrPSc form [72,73].
Critchley et al [73] found in SPR experiments that while both
bound to membranes, the oligomerizing b-sheet form PrPSc bound
more strongly than the a-helical form, in contrast to our
experience with SBD. Similar findings were reported by Inaba
et al for Ab full-length peptide [74]. However, the a-helical form
of Prp also aggregated at high concentrations, particularly in the
presence of negatively charged membranes [73]. The binding was
stronger at low pH for both forms. This was attributed to
protonation of histidines in PrP, and consequently stronger
electrostatic interactions with the negative membrane.
Interestingly, this is reminiscent of the behaviour of Ab, which
also binds more strongly at low pH, and contains two histidines at
positions 13 and 14 of the peptide, at least one of which is involved
in binding to the sialic acid of GM1 [69]. In that report, it was
found that the more N-terminal region of Ab, which is within the
sequence that we used for the SBD (aa 13–17) is responsible for the
interaction, and is induced upon interaction with the ganglioside
to convert from unstructured to a-helix. Accordingly, (and
consistent with [31]) binding to GM1 was unrelated to oligomer-
ization in their findings. In our earlier characterization of SBD, we
described a similar effect to these observations on Ab, where low
pH not only strengthened binding considerably in liposome
capture experiments, but it changed the ganglioside preference
from more negative polysialylated gangliosides like GT1b and
GD1a to mono-sialylated GM1 [38](see [59]).
Our results that more aggregation-prone species of the peptide
interact less well with the membrane are perhaps surprising in light
of the fact that toxins such as CtxB bind more tightly upon
oligomerization, as one would expect, and that clustering of
ganglioside targets by toxins and viruses indeed seems to be part of
the infective strategy of these agents by fostering uptake into
endocytic domains [1,7,9]. Additionally, Ab monomers have been
reported to bind with less overall affinity than aggregates, although
this comes about because of a difference in relative on- and off-
rates between the two species [35,74]. Even though the more
aggregation-prone variants of SBD had an apparently lower
affinity for ganglioside-containing surfaces by SPR, as well as
lower bound fractions by FCS on cell membranes, their longer
diffusion coefficients indicate that they were less mobile at the cell
surface, once bound. This may be consistent with the findings of
Kremer et al [75] who determined by fluorescence anisotropy that
aggregated Ab increased membrane order, and that this was
enhanced by the presence of gangliosides. The results presented
here also demonstrate that the b-sheet forming part of the Ab
peptide is not necessary to induce aggregation at the membrane.
Conclusion
In this study, we observed a striking inverse correlation between
the binding ability of SBD variants to ganglioside-containing
membranes, and membrane-induced aggregation. Aggregation of
the peptide, rather than increasing binding to cells, correlated with
low binding and very slow diffusion behaviour. As yet, we cannot
distinguish whether aggregation inhibits binding, or weak binding
fosters aggregation–however, aggregation occurring only at the
membrane implies the latter. This may suggest a mechanism
whereby a stronger interaction of Ab (or any membrane binding
peptide) with ganglioside targets, in the absence of the formation of
higher order structures, could favour low-valency binding vs.
aggregation. More generally, the information from this study
begins to tell us about correlations between the aggregation
behaviour of a peptide, its interaction with particular lipids, and its
Figure 8. Labelling of neuroblastoma SH-SY5Y with SBD
variants. SBD was incubated with neuroblastoma SH-SY5Y for 30 mins
at room temperature, washed, and imaged by widefield fluorescence
microscopy after 1 hour. Five mid-cell optical sections were projected
after deconvolution. All peptides can be seen to have been
endocytosed into vesicular compartments. Peptides were: A) PEG-K16-
NH3; B) PEG-K16-COO-; C) PEG-E16-NH2; D) PEG-E16-COO-; E) AEEAc-
E16-COO-. Scale bar is 20 mm.
doi:10.1371/journal.pone.0051222.g008
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membrane diffusion properties. Once enough data is accumulated
describing the relationship between peptide features and their
behaviours on membranes, it may be possible to construct peptides
that are engineered toward particular interactions with the
membrane.
Supporting Information
Figure S1 SPR curves showing association at ,110 sec
and dissociation at ,350 sec of the different SBD
variants, in response units (RU) on the Y-axis, and time
(seconds) on the X-axis. The compositions and molar ratios of
the liposomes immobilized on the L1 chip are given in the titles of
each graph. Red: PEG-K16-NH2; Green: PEG-K16-COO-; Blue:
PEG-E16-NH2; Magenta: PEG-E16-COO-; Gray: AEEAc-E16-
COO-.
(TIF)
Figure S2 Ramachandran plots (A), with Phi (x-axis)
and Psi (y-axis) showing the dihedral angles of the
peptide backbone, which usually reflect the secondary
structure; (B) secondary structure propensity (DSSP)
analysis from 200 ns REMD simulations, with each
number representing the fraction of the time that each
structure occurs. The effect on SBD peptide structure was first
compared between the AEEAc and the PEG linker. The
distribution of structural features appeared to be very similar
between the two. In the absence of linker, the distribution of
structural features was compared between the four variants, either
E16 or K16, and with carboxy (COO-) or amide (NH2) termini, in
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